Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

11:45 BST Daiichi Sankyo Presents Updated Results of [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Expressing Advanced Colorectal Cancer at 2018 European Society for Medical Oncology (ESMO) Congress

- Updated analysis from ongoing phase 1 study of [fam-] trastuzumab deruxtecan (DS-8201) demonstrated a confirmed overall response rate of 15.8...


20 Oct, 2018, 14:04 BST Cantargia Presented Positive Phase I Clinical Data with Lead Candidate CAN04 at ESMO

The antibody CAN04 was well tolerated and 6 mg/kg is a safe dose - Effects on biomarkers and 5 of 13 evaluable patients achieved stable...


19 Oct, 2018, 23:59 BST BERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress

BERG LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the...


19 Oct, 2018, 13:23 BST Seqirus Cell-based Influenza Vaccine Nears European Approval

Seqirus, a global leader in influenza prevention, today announced that its cell-based quadrivalent influenza vaccine (QIVc) has received a...


19 Oct, 2018, 09:32 BST Singlera Genomics and Fudan University unveil results showing Pan-Cancer Early Detection in the Taizhou Longitudinal Study

Fudan University's Taizhou Health Science Institute and Singlera Genomics, a UC San Diego spinout company focused on non-invasive early cancer...


19 Oct, 2018, 08:00 BST Menarini Progresses Into the Clinic With MEN1611, a PI3K Inhibitor for the Treatment of HER2 Positive Metastatic Breast Cancer

Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety...


19 Oct, 2018, 07:38 BST InDex Pharmaceuticals Publishes Post-hoc Analysis of the COLLECT Study

InDex Pharmaceuticals Holding AB (publ) today announced the publication of a post-hoc analysis of COLLECT study data. COLLECT was a clinical study...


19 Oct, 2018, 07:00 BST Norgine to Present Data for Plenvu® and Xifaxan® at the United European Gastroenterology Week

- Seven PLENVU® related posters - one poster demonstrating PLENVU® higher efficacy compared to standard of care - Three XIFAXAN®...


18 Oct, 2018, 18:40 BST Singlera Genomics unveils results of ColonES study demonstrating detection of advanced adenoma and colorectal cancer

In collaboration with Fudan University Shanghai Cancer Center and Nanfang Hospital of Southern Medical University, Singlera Genomics, a UC San...


18 Oct, 2018, 13:43 BST Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes

Expanded collaboration with the Bill & Melinda Gates Foundation will leverage Oxitec's Friendly™ biological engineering platform to develop...


18 Oct, 2018, 13:00 BST Daiichi Sankyo Initiates Phase 1 Study of AXL Inhibitor DS-1205 in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer

- First-in-human phase 1 study to assess the safety and tolerability of DS-1205, a highly selective investigational AXL inhibitor, in combination...


18 Oct, 2018, 11:00 BST Sysmex Inostics' OncoBEAM™ Platform Demonstrates Superior Detection of Clinically-relevant Mutations for Therapy Selection and Molecular Monitoring for Lung and Colon Cancers

Data presented at the European Society of Medical Oncology (ESMO) 2018 meeting in Munich, Germany by three clinical oncology research groups...


18 Oct, 2018, 06:00 BST UCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis Into Confirmatory Development Phase

- Positive outcomes in proof-of-concept study with subcutaneous rozanolixizumab in patients with myasthenia gravis (MG): clinically...


18 Oct, 2018, 05:01 BST The Impact of Fragility Fractures due to Osteoporosis is Being Ignored

- New survey reveals that 61 per cent of women over 60 have little or no knowledge of osteoporosis,[1] despite the fact that one in three...


18 Oct, 2018, 05:01 BST The Impact of Fragility Fractures due to Osteoporosis is Being Ignored

- New survey reveals that 61 per cent of women over 60 have little or no knowledge of osteoporosis,[1] despite the fact that one in three...


17 Oct, 2018, 13:00 BST Daiichi Sankyo Submits Application in Japan for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML

-- Submission based on results of pivotal phase 3 QuANTUM-R study and open-label phase 2 study in Japan of quizartinib in patients with...


17 Oct, 2018, 12:00 BST Alkermes Highlights Ongoing Commitment to Research and Innovation in Depression and Schizophrenia at 2018 Psych Congress

Alkermes plc (Nasdaq: ALKS) today announced the presentation of 10 posters at the upcoming 31st Annual Psych Congress (Psych Congress) in Orlando,...


17 Oct, 2018, 06:00 BST Pharming Reports Positive Data From First Investigator-initiated Study of rhC1-Inhibitor (RUCONEST®) in Contrast-induced Nephropathy

Primary Endpoint was met, with rhC1INH treatment reducing neutrophil gelatinase-associated lipocalin (NGAL), a widely recognized marker of acute...


16 Oct, 2018, 20:22 BST UPDATED -- JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer

JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and Phase III Clinical Trial...


16 Oct, 2018, 17:25 BST HBKU Researcher Competes in Season 10 of Stars of Science

Breaking new ground for early Parkinson's diagnostics, Qatar-based hopeful qualifies among top nine contestants in Arab world's leading...


16 Oct, 2018, 07:58 BST BioInvent to Expand Pipeline With New Development Programs in Solid Cancer

Aim is to add three clinical programs in solid cancer starting H1 2019 BioInvent Capital Markets Day in Stockholm on December 10 to provide...


15 Oct, 2018, 14:00 BST JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer

JHL Biotech announced today that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and Phase III Clinical...


15 Oct, 2018, 12:00 BST Bluegrass Vascular Announces Enrollment Completion Of International Post-Market SAVE Registry With Early Positive Results

IDE study, SAVE-US, expands patient enrollment and further demonstrates positive trends Bluegrass Vascular Technologies (Bluegrass...


15 Oct, 2018, 11:40 BST Sysmex Inostics' OncoBEAM™ Liquid Biopsy Technology Demonstrates Utility for Clinical Management of Melanoma Patients Undergoing Treatment With Targeted Therapy and Immune Checkpoint Inhibitors

Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce...


15 Oct, 2018, 06:20 BST Targovax Reports Encouraging Disease-free Survival (DFS) Data From Tg01 Trial in Resected Pancreatic Cancer

Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, today...